Intel India And Indian Scientists Are Aiming To Use AI Solutions To Cope With COVID-19

Intel India is teaming up with the International Institute of Information Technology (IIIT) Hyderabad and the Council of Scientific and Industrial Research (CSIR) to work on a new COVID-19 testing solution with faster speed but less expensive cost. The team will also develop an AI-enabled risk model for patients in quest of finding an effective cure based on COVID-19 genome sequencing.

According to a statement from the Ministry of Science and Technology, Intel India’s end-to-end system includes a series of apps, testing devices along with data aggregation gateways, and a special platform that will work as an AI model hub. The partnership between it and IIIT-Hyderabad and CSIR will mainly focus on not only genomics but also AI and big data to enhance complementary strengths in the time of COVID-19 pandemic.

In the meantime, CSIR labs are responsible for carrying out diagnosis processes with the aid of hospitals across the country. At IIIT-Hyderabad, multiple “risk stratification” algorithms are under development for vaccine and drug discovery when we’re all preparing to cope with the widespread virus in the long run.

CSIR is launching a flagship program called New Millennium Indian Technology Leadership Initiative (NMITLI) to study a COVID-19 therapy based on human monoclonal antibodies. Previously, one of CSIR labs in Durgapur has successfully invented a robotic device that aims to help maintain physical distance between frontline healthcare staff and infected patients.

>>> Startup At IIT Hyderabad Is Working On A Low-Cost Ventilator